Šalis: Australija
kalba: anglų
Šaltinis: Department of Health (Therapeutic Goods Administration)
ranitidine hydrochloride, Quantity: 167.5 mg
Nova Pharmaceuticals Australasia Pty Ltd
Ranitidine hydrochloride
Tablet, film coated
Excipient Ingredients: hypromellose; Castor Oil; croscarmellose sodium; iron oxide yellow; colloidal anhydrous silica; purified talc; microcrystalline cellulose; magnesium stearate; titanium dioxide
Oral
14
Not scheduled. Not considered by committee
Provides effective long-lasting 12-hour relief from heartburn and acid indigestion due to gastro-oesophageal reflux.
Visual Identification: Creamish to yellowish coloured, convex, film-coated tablet, impressed with the identifying letters ?R? and ?I? on either side of a central division line on one face.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2013-05-23